Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
International Journal of Obesity
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
January 2002, Volume 26, Number 1, Pages 137-141
Table of contents    Previous  Abstract  Next   Full text  PDF
SHORT COMMUNICATION
Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia
J H Thakore1, J N Mann2, I Vlahos3, A Martin3 and R Reznek3

1Neuroscience Centre, St Vincent's Hospital, Dublin, Ireland

2St Clement's Hospital, London, UK

3Academic Department of Radiology, St Bartholomew's Hospital, London, UK

Correspondence to: J H Thakore, Neuroscience Centre, St Vincent's Hospital, Richmond Rd, Fairview, Dublin 3, Ireland. E-mail: jthakore@indigo.ie

Abstract

OBJECTIVE: To investigate visceral fat distribution in patients with schizophrenia.

DESIGN: Cross sectional study using CT scanning in patients with drug-naive and drug-free schizophrenia.

SUBJECTS: Fifteen (13 men and two women) subjects with schizophrenia (mean age 33.7 y; mean body mass index (BMI)=26.7 kg/m2), and 15 age- and sex-matched controls (mean age 30.5 y; mean BMI=22.8 kg/2).

MEASUREMENTS: Various fatness and fat distribution parameters (by CT scanning and anthropometry) and 16:00 h plasma cortisol.

RESULTS: In comparison to controls, patients with schizophrenia had central obesity and had significantly higher levels of plasma cortisol. Furthermore, previous neuroleptic exposure did not appear to influence these findings as both drug-naive and drug-free patients had equally high levels of visceral fat deposition.

CONCLUSION: Central obesity is a well recognized risk factor in developing certain general medical conditions. This study shows that patients with schizophrenia have increased intra-abdominal fat which may provide one explanation for why they die prematurely.

International Journal of Obesity (2002) 26, 137-141. DOI: 10.1038/sj/ijo/0801840

Keywords

schizophrenia; cortisol; imaging

Received 17 April 2001; revised 6 June 2001; accepted 2 July 2001
January 2002, Volume 26, Number 1, Pages 137-141
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 2002 Nature Publishing Group